JACOB MANSY: Open Payments
NPI 1700327434 · LA JOLLA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$530 in 24 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $225 · 2025 $530
Food & beverage: $530
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 7 | $124 |
| Novo Nordisk Inc | 4 | $99 |
| AstraZeneca Pharmaceuticals LP | 3 | $81 |
| Madrigal Pharmaceuticals | 4 | $80 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $65 |
| Gilead Sciences, Inc. | 2 | $45 |
| ORPHALAN INC | 1 | $21 |
| Eurofins Viracor, LLC | 1 | $14 |
Products named: PREVYMIS, Wegovy, REZDIFFRA, LIVTENCITY, CUVRIOR.
Industry payments across CA — which companies pay providers there.
